Massot O, Grimaldi B, Bailly J M, Kochanek M, Deschamps F, Lambrozo J, Fillion G
Unité de Pharmacologie Neuro-Immuno-Endocrinienne, Institut Pasteur, 25-28 rue du docteur Roux, Paris, France.
Brain Res. 2000 Mar 6;858(1):143-50. doi: 10.1016/s0006-8993(99)02486-5.
It was previously suggested that exposure to magnetic fields (MFs) could generate dysfunction of the CNS. The physiological manifestations described lead us to postulate that these symptoms might be related to a dysfunction of the serotonergic system and particularly of the 5-HT(1B) receptors. Accordingly, MFs could modify the conformation of these receptors altering their functional activities. In rat brain membrane preparations, we showed that the affinity constant of 5-HT for 5-HT(1B) receptors was modified under exposure to MFs since K(d) varied from 4.7+/-0.5 to 12+/-3 nM in control and exposed (2.5 mT) membranes, respectively. This effect was intensity-dependent (the sigmoidal dose-response curve was characterized by an EI(50) of 662+/-69 microT and a maximal increase of 321+/-13% of the control K(d)), reversible, temperature-dependent and specific to the 5-HT(1B) receptors. Similar results have also been obtained with the human 5-HT(1B) receptors. In parallel assays, the functional activity of 5-HT(1B) receptors was investigated. The capacity of a 5-HT(1B) agonist to inhibit the cAMP production was reduced by 37% (53.7+/-3.5% to 33.7+/-4.1%) following exposure to MFs and the cellular activity of the receptors (inhibition of the synaptosomal release of 5-HT) also was markedly reduced (66.5+/-3.2% to 28.5+/-4.2%). These results clearly show that in in vitro assays, MF specifically interacts with 5-HT(1B) receptors, inducing structural changes of the protein that result in a functional desensitization of the receptors. Thus, in vivo, exposure to MFs may lead to physiological changes, particularly in the field of mood disorders where the 5-HT system is strongly involved.
先前有研究表明,暴露于磁场(MFs)可能会导致中枢神经系统功能障碍。所描述的生理表现使我们推测,这些症状可能与血清素能系统功能障碍有关,尤其是5 - HT(1B)受体功能障碍。因此,磁场可能会改变这些受体的构象,从而改变其功能活性。在大鼠脑膜制剂中,我们发现,暴露于磁场下,5 - HT对5 - HT(1B)受体的亲和常数发生了改变,在对照膜和暴露于2.5 mT磁场的膜中,解离常数(K(d))分别从4.7±0.5 nM变化到12±3 nM。这种效应具有强度依赖性(S形剂量反应曲线的半数效应强度(EI(50))为662±69 μT,对照K(d)的最大增加量为对照值的321±13%),是可逆的、温度依赖性的,且对5 - HT(1B)受体具有特异性。在人类5 - HT(1B)受体上也得到了类似的结果。在平行实验中,对5 - HT(1B)受体的功能活性进行了研究。暴露于磁场后,5 - HT(1B)激动剂抑制环磷酸腺苷(cAMP)生成的能力降低了37%(从53.7±3.5%降至33.7±4.1%),受体的细胞活性(抑制5 - HT的突触体释放)也显著降低(从66.5±3.2%降至28.5±4.2%)。这些结果清楚地表明,在体外实验中,磁场特异性地与5 - HT(1B)受体相互作用,诱导蛋白质结构变化,导致受体功能脱敏。因此,在体内,暴露于磁场可能会导致生理变化,特别是在5 - HT系统密切相关的情绪障碍领域。